- Price
Supplier Type
- Manufacturer
- contract manufacturer
- custom synthesis
- Reagent
Supplier Region
- Telangana(5)
- Maharashtra(2)
- Hyderabad(3)
- Gujarat(3)
- Karnataka(1)
Purity
- United States Pharmacopeia (USP) Reference Standard
- pharmaceutical secondary standard, certified reference material
- 99%
- >98.0%(T)(HPLC)
- 98% to 99%
- >98%
- 98%
- 96%
- 90 % Above
Package
- 5G
- 50010500 mg and 1.0 gm
- 25mg
- 50MG
- 100MG
- 250MG
- 1G
- 1kg
- 5kg
- 10kg
- 25kg
- 1MT
- 25kgs fiber /hdpe drums
- 50kgs
- 2852.85 GM
- 100500100mg or 500 mg
- 25kgs
5-Difluoromethoxy-2-{[(3,4-dimethoxy-2-pyridinyl)methyl]thio}-1H-benzimidazole
- CAS:102625-64-9
- MF:C16H15F2N3O3S
- MW:367.37
- EINECS:1806241-263-5
- Melting point::
- 110-118°C
- Boiling point::
- 526.3±60.0 °C(Predicted)
- Density :
- 1.43±0.1 g/cm3(Predicted)
- storage temp. :
- Sealed in dry,2-8°C
- solubility :
- DMSO (Slightly), Methanol (Slightly)
- form :
- neat
- pka:
- 8.97±0.10(Predicted)
- color :
- Off-White to Light Brown
- BRN :
- 5358607
- InChIKey:
- UKILEIRWOYBGEJ-UHFFFAOYSA-N
- Symbol(GHS)
GHS07
- Signal word
- Warning
- Hazard statements
- H302-H315-H319-H335
- Precautionary statements
- P261-P305+P351+P338
Pantoprazole USP Related Compound-B / Pantoprazole EP Impurity-B (Sulfide) 102625-64-9
5-Difluoromethoxy-2-[[3,4-dimethoxy-2-pyridinyl)methyl]thio]-1H-benzimidazole
5-Difluoromethoxy-2-[[3,4-dimethoxy-2-pyridinyl)methyl]thio]-1H-benzimidazole 102625-64-9
5-Difluoromethoxy-2-[[3,4-dimethoxy-2-pyridinyl)methyl]thio]-1H-benzimidazole
5-Difluoromethoxy-2-[[3,4-dimethoxy-2-pyridinyl)methyl]thio]-1H-benzimidazole 102625-64-9
5-Difluoromethoxy-2-[[3,4-dimethoxy-2-pyridinyl)methyl]thio]-1H-benzimidazole 102625-64-9
5-Difluoromethoxy-2-[[3,4-dimethoxy-2-pyridinyl)methyl]thio]-1H-benzimidazole 102625-64-9
5-Difluoromethoxy-2-[[3,4-dimethoxy-2-pyridinyl)methyl]thio]-1H-benzimidazole 102625-64-9